-
Novel diarylpyrimidines and diaryltriazines as potent HIV-1 NNRTIs with dramatically improved solubility: a patent evaluation of US20140378443A1.
Author: Huang B, Kang D, Yang J, Zhan P, Liu X.
Journal: Expert Opin Ther Pat. 2016;26(2):281-9. doi: 10.1517/13543776.2016.1113256. Epub 2015 Nov 11.
-
RGD mimetics γ-AApeptides and methods of use (US 20,140,004,039 A1): a patent evaluation.
Author: Wu H, Jiang J, Xu H, Li Q, Cai J.
Journal: Expert Opin Ther Pat. 2016 Jan;26(1):131-7. doi: 10.1517/13543776.2016.1111337. Epub 2015 Nov 11.
-
Novel serotonin receptor 2 (5-HT2R) agonists and antagonists: a patent review (2004-2014).
Author: Yang Y, An S, Liu Y, Guo XX, Gao L, Wei JF, Xu TR.
Journal: Expert Opin Ther Pat. 2016 Jan;26(1):89-106. doi: 10.1517/13543776.2016.1113257. Epub 2015 Nov 26.
-
Analysis of anti-asthmatic drug patents published in China between 2004 and 2013.
Author: Xie H, Zhang H, Cao K, He P, Dai H, He S.
Journal: Expert Opin Ther Pat. 2016;26(3):363-76. doi: 10.1517/13543776.2016.1136289. Epub 2016 Jan 19.
-
Topical composition for treating diabetic cataracts: a patent evaluation (WO2015026380A1).
Author: Hao X, Han Z, Zhu C.
Journal: Expert Opin Ther Pat. 2016 Jun;26(6):731-5. doi: 10.1517/13543776.2016.1163339. Epub 2016 Mar 21.
-
Research and development of antibiotics: insights from patents and citation network.
Author: Zhang M, Kong X, Zheng J, Wan JB, Wang Y, Hu Y, Shao R.
Journal: Expert Opin Ther Pat. 2016 May;26(5):617-27. doi: 10.1517/13543776.2016.1167877. Epub 2016 Apr 6.
-
Novel compound, organic cation transporter 3 detection agent and organic cation transporter 3 activity inhibitor, WO2015002150 A1: a patent evaluation.
Author: Hu T, Wang L, Pan X, Qi H.
Journal: Expert Opin Ther Pat. 2016 Aug;26(8):857-60. doi: 10.1080/13543776.2016.1180364. Epub 2016 Apr 29.
-
Telomerase inhibitors: a patent review (2010-2015).
Author: Man RJ, Chen LW, Zhu HL.
Journal: Expert Opin Ther Pat. 2016 Jun;26(6):679-88. doi: 10.1080/13543776.2016.1181172. Epub 2016 May 12.
